Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Direct to consumer advertising works in correction facilities

Jeffrey Knuppel, MD
Meds
October 25, 2011
Share
Tweet
Share

One might assume that inmates in correctional facilities would not be influenced by big pharma’s direct-to-consumer advertising (DTCA) strategies. After all, their communication channels with the outside world have largely been silenced.

However, many do have access to television. And despite an increase in online pharmaceutical marketing, TV remains a common medium for trying to persuade patients to “ask your doctor” about drug X. Inmates also read magazines, another common advertising medium.

I’ve seen many inmates who have asked about prescription sleep medications (often costing close to $200 per month) that they saw advertised. “Why can’t I get some of that?” I’m often asked. I explain that it would be very unusual for correctional formularies to carry such medications. I explain that even my own health insurance plan, which is quite comprehensive, does not cover many of the newer sleep medications.

I’ve also frequently been asked about Abilify, a newer antipsychotic drug that has been marketed for use in combination with an antidepressant to treat depression. It’s not uncommon for a patient to have been on a starting dose of a generic antidepressant (pennies per pill in my correctional system) for a few weeks and then ask me about adding Abilify because they don’t think the antidepressant is working well enough.

If the antidepressant isn’t working sufficiently, then the next step would be to increase the dose of their current medication, not to add something else. When I explain that increasing their dose of is not only the next logical step but that adding Abilify, even at a low dose, will cost close to $500 per month and increase their risk of diabetes, high blood pressure, and other serious health problems, I usually get an “Oh, okay, let’s increase my antidepressant” response. They usually seem quite surprised when they learn just how expensive Abilify actually is.

But this necessary discussion also takes extra time–time which costs taxpayers money. Primary care providers also have to spend time addressing such DTCA issues in jails and prisons.

According to Wikipedia, New Zealand and the U.S. are the only two nations that permit DTCA. A U.S. Government Accountability Office report (pdf) in November 2006 revealed that in 2005, drug companies spent $4.2 billion on DTCA and $31.4 billion on research and development.

The report explains:

…studies we reviewed found that increases in DTC advertising have contributed to overall increases in spending on both the advertised drug itself and on on other drugs that treat the same conditions. For example, one study of 64 drugs found a median increase in sales of $2.20 for every $1 spent on DTC advertising. Consumer surveys suggest that DTC advertising increases utilization of drugs by prompting some consumers to request the advertised drugs from their physicians, who studies find are generally responsive to these requests. The surveys we reviewed found that between 2 and 7 percent of consumers who saw DTC advertising requested and ultimately received a prescription for the advertised drug.

So, DTCA clearly works. But is prescribing in correctional settings actually influenced by DTCA? I don’t know. Not surprisingly, I haven’t found any data about this topic. I suspect that it influences it some but not to the extent that it does in non-correctional settings (since correctional formularies are typically more restrictive than community formularies and because samples are not used in corrections). But if it influences prescribing to inmates at all, then it’s costing taxpayers extra money, money that’s not available in the current economic climate.

DTCA benefits nobody but the bottom lines of the drug companies. Contrary to what they want you to believe, it does not benefit patients. Patients deserve access to quality, unbiased health information. And with so much money at stake, the conflict of interest will always be too great for us to assume that their information is anything more than a sales pitch. But it’s been a very effective pitch, one that’s even managed to reach and influence those who are incarcerated.

Jeffrey Knuppel is a psychiatrist.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

5 tips to evaluate medical websites

October 25, 2011 Kevin 8
…
Next

PSA testing: Information is better than ignorance

October 26, 2011 Kevin 2
…

ADVERTISEMENT

Tagged as: Medications

Post navigation

< Previous Post
5 tips to evaluate medical websites
Next Post >
PSA testing: Information is better than ignorance

ADVERTISEMENT

More by Jeffrey Knuppel, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Physicians who treat inmates are at greater risk of litigation

    Jeffrey Knuppel, MD
  • a desk with keyboard and ipad with the kevinmd logo

    A psychiatrist on the compulsion behind running and exercise

    Jeffrey Knuppel, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Where do we draw the line on criminalizing mistakes?

    Jeffrey Knuppel, MD

More in Meds

  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • A psychiatrist’s 20-year journey with ketamine

    Muhamad Aly Rifai, MD
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • Every medication error is a system failure, not a personal flaw

    Muhammad Abdullah Khan
  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why I left the clinic to lead health care from the inside

      Vandana Maurya, MHA | Conditions
    • How doctors can think like CEOs [PODCAST]

      The Podcast by KevinMD | Podcast
    • A surgeon’s testimony, probation, and resignation from a professional society

      Stephen M. Cohen, MD, MBA | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • Affordable postpartum hemorrhage solutions every OB/GYN can use worldwide [PODCAST]

      The Podcast by KevinMD | Podcast
    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
    • Psychiatrist tests ketogenic diet for mental health benefits

      Zane Kaleem, MD | Conditions
    • The hidden rewards of a primary care career

      Jerina Gani, MD, MPH | Physician
    • Why physicians should not be their own financial planner

      Michelle Neiswender, CFP | Finance
    • Why doctors regret specialty choices in their 30s

      Jeremiah J. Whittington, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • Why I left the clinic to lead health care from the inside

      Vandana Maurya, MHA | Conditions
    • How doctors can think like CEOs [PODCAST]

      The Podcast by KevinMD | Podcast
    • A surgeon’s testimony, probation, and resignation from a professional society

      Stephen M. Cohen, MD, MBA | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
  • Recent Posts

    • Affordable postpartum hemorrhage solutions every OB/GYN can use worldwide [PODCAST]

      The Podcast by KevinMD | Podcast
    • When cancer costs too much: Why financial toxicity deserves a place in clinical conversations

      Yousuf Zafar, MD | Physician
    • Psychiatrist tests ketogenic diet for mental health benefits

      Zane Kaleem, MD | Conditions
    • The hidden rewards of a primary care career

      Jerina Gani, MD, MPH | Physician
    • Why physicians should not be their own financial planner

      Michelle Neiswender, CFP | Finance
    • Why doctors regret specialty choices in their 30s

      Jeremiah J. Whittington, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Direct to consumer advertising works in correction facilities
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...